Holen Sie sich die Stockscreener-App
4.50
1.75%
-0.08
Handel nachbörslich:
4.63
0.13
+2.89%
Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
508.79%
10.74
|
1.764 | 1.574 | 1.339 | 1.726 |
Operating Expenses
|
66.31%
9.251
|
27.46 | 15.51 | 22.78 | 23.31 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
66.31%
9.251
|
27.46 | 15.51 | 22.78 | 23.31 |
| Operating Income/Loss |
105.79%
1.488
|
-25.70 | -13.93 | -21.44 | -21.58 |
| Nonoperating Income/Loss |
11.76%
1.035
|
1.173 | 1.401 | 1.723 | 1.787 |
| Income/Loss From Continuing Operations Before Tax |
143.79%
10.74
|
-24.53 | 1.574 | 1.339 | -19.80 |
| Income/Loss From Continuing Operations After Tax |
110.29%
2.523
|
-24.53 | -12.53 | -19.72 | -19.80 |
|
Net Income/Loss
|
110.29%
2.523
|
-24.53 | -12.53 | -19.72 | -19.80 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.44%
191.55
|
190.71 | 1.3641 | 189.00 | 188.04 |
| Diluted Average Shares |
0.89%
192.40
|
190.71 | -367.06 | 189.00 | 188.04 |
| Basic Earnings Per Share |
107.69%
0.01
|
-0.13 | -0.07 | -0.10 | -0.11 |
| Diluted Earnings Per Share |
107.69%
0.01
|
-0.13 | -0.07 | -0.10 | -0.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):